Rentschler Biopharma, XL-Protein tie up deal to manufacture therapeutic DNase I

GERMANY – Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and XL-protein, a privately held biopharmaceutical company in Germany, have formed a partnership to develop a long-acting, hyperactive recombinant human deoxyribonuclease I (DNase I). The new innovation utilized Rentschler Biopharma’s expertise in bioprocess development expertise and XL- protein proprietary’s PASylation technology to develop a modified DNase I with significantly increased activity and extended pharmacokinetic profile. Thilo Grob, vice president Process Science at Rentschler Biopharma SE, commenting on this development said: “This highly successful collaboration was…

Read More

BioNTech inks mRNA vaccine production facility deal with Rwanda, Senegal

SENEGAL – BioNTech has signed an agreement with the Rwandan government and Institut Pasteur de Dakar in Senegal on the construction of the first mRNA vaccine manufacturing facility in Africa starting in mid-2022, to help the continent ease health inequalities compared with other world regions. BioNTech, which developed the western world’s most widely used COVID-19 shots with partner Pfizer, will initially build a production line with an annual capacity of 50 million doses that could be used to make vaccines for such diseases as malaria and tuberculosis as well as…

Read More

GSK Consumer Healthcare rolls out 3-year pharmacist support program

UNITED KINGDOM – GSK Consumer Healthcare has unveiled a three-year program to support the pharmacy profession with additional practical resources, mental health provisions, and proposed policy changes as part of its new report Standing with Pharmacists in the Age of Self-Care. The new report summarizes findings from a roundtable hosted earlier this year by GSK Consumer Healthcare in collaboration with the International Pharmaceutical Federation (FIP), which brought together pharmacy leaders, policy experts, and industry leaders to discuss the critical role of pharmacy in the age of self-care in the aftermath…

Read More

Rwanda Biomedical center receives a EUR 27M patronage by EU to further research

RWANDA – Rwanda Biomedical Centre has received a EUR 27 million backing from the European Investment Bank (IEB)to upgrade the National Health Laboratory by strengthening epidemic and pandemic preparedness by improving diagnosis surveillance and research. The support is part of Government efforts to invest in the COVID-19 National Response Plan priority. Similarly, this is the first EIB health project in Rwanda and largest ever EIB health engagement in East Africa. The largest ever EIB financing for health investment in East Africa will finance construction of a new medical diagnosis and…

Read More

Moderna to supply over 100 million Covid-19 vaccines to the AU

ETHIOPIA – Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced a new Memorandum of Understanding (MoU) to make up to 110 million doses of the Moderna COVID-19 vaccine available to the African Union. The Company is prepared to deliver the first 15 million doses in the fourth quarter of 2021, 35 million doses in the first quarter of 2022, and up to 60 million doses in second quarter 2022. All doses are offered at Moderna’s lowest tiered price, in line with the Company’s global…

Read More

Aenova invests in aseptic fill/finish facility for vaccines and biologics

ITALY – Aenova has announced a significant increase in cutting-edge aseptic production area at Latina, Italy, facility featuring a completely new high-speed flexible line for vials and prefilled syringes (PFS), as well as a completely new compounding area. This area has the capacity to store more than 80 million vials and 180 million prefilled syringes for vaccines and biologics. Additional capacity expansions to a total of four high-speed filling lines are also planned. Aenova has many years of experience as a global contract development and manufacturing organization (CDMO) in the…

Read More

Nigeria’s teleco operator 9mobile partners Medicaid to combat cancer

NIGERIA – In line with its commitment to support initiatives that promote healthcare, Nigeria’s telecom operator, 9mobile, has partnered with Medicaid Foundation to support the fight against cancer. Both organizations held a six kilometer-walk against cancer, themed Walk Away Cancer’ in the central business district of Abuja, Nigeria. The event was put together to create awareness on the devastating effect of cancer, drum up support for the fight against the disease, and highlight the role of early detection in saving lives. Chief Executive Officer, MEDICAID, Dr. Zainab Bagudu, who convened…

Read More

Aptar Pharma in exclusive partnership with Stallergenes Greer to develop new medical device

USA – Aptar Pharma, a global leader in drug delivery systems, services, and active material science solutions, has formed an exclusive partnership with Stallergenes Greer, a global healthcare company specializing in allergen immunotherapy (AIT), to create the first-of-its-kind connected drug delivery device. The partnership will also see to the development of companion mobile app for patients undergoing Stallergenes Greer’s AIT treatments with sublingual solutions. Non-compliance with an AIT schedule and premature discontinuation of treatment continue to be issues in AIT management. This innovative, user-friendly connected device will help to improve…

Read More

GTP Bioways invests US$14 million in biopharma production lines

FRANCE – GTP Bioways, a contract development and manufacturing organization (CDMO) specializing in biotherapies and nanotherapies, is set to invest US$14 million in two new biopharmaceutical production lines at its Toulouse, France. The first line will be dedicated to microbial production (bacteria and yeast). It will be operational in the first quarter of 2023, with a capacity of 300L, allowing GTP Bioways to respond to a rapidly growing market. GTP Bioways claims to be France’s only CDMO with a GMP (Good Manufacturing Practices) unit for producing proteins with therapeutic or…

Read More

Study suggests cloud computing as a game changer in Africa’s healthcare industry

KENYA – Cloud computing is one of the leading trends in digital transformation for 2021 and beyond with Africa not being left behind, a move that has been deemed to revolutionize the healthcare scene in the continent. Leading tech companies have already been offering this technology but the increased use of online platforms since the pandemic started is increasing its popularity even more. The COVID-19 pandemic has shown that many healthcare organizations do not have the necessary agility and business continuity programs or technologies to support them during crises. It…

Read More